- The Role of Common Pharmaceutical Agents on the Prevention and Treatment of Pancreatic Cancer
-
Amin S, Boffetta P, Lucas AL
- KMID: 2412062
- Gut Liver.
- 2016 Sep;10(5):665-671.
- doi: 10.5009/gnl15451
Survival from pancreatic cancer remains poor. Conventional treatment has resulted in only marginal improvements in survival compared with survival in the previous several decades. Thus, considerable interest has emerged regarding... -
- CITED
-
- Close
- SHARE
-
- Close
- Familial Pancreatic Cancer and the Future of Directed Screening
-
Welinsky S, Lucas AL
- KMID: 2395380
- Gut Liver.
- 2017 Nov;11(6):761-770.
- doi: 10.5009/gnl16414
Pancreatic cancer (PC) is the third most common cause of cancer-related death in the United States and the 12th most common worldwide. Mortality is high, largely due to late stage... -
- CITED
-
- Close
- SHARE
-
- Close
- There Is No Advantage to Transpapillary Pancreatic Duct Stenting for the Transmural Endoscopic Drainage of Pancreatic Fluid Collections: A Meta-Analysis
-
Amin S, Yang DJ, Lucas AL, Gonzalez S, DiMaio CJ
- KMID: 2389245
- Clin Endosc.
- 2017 Jul;50(4):388-394.
- doi: 10.5946/ce.2016.091
BACKGROUND/AIMS: Options for the endoscopic management of symptomatic pancreatic fluid collections (PFCs) include transmural drainage (TM) alone, transpapillary drainage (TP) alone, or a combination of both drainage method (CD). There... -
- CITED
-
- Close
- SHARE
-
- Close
- Bisphosphonate Use Does Not Impact Survival in Patients with Pancreatic Cancer: A Propensity Score Matching Analysis
-
Zylberberg HM, Rustgi SD, Yang A, Aronson A, Kessel E, Amin S, Lucas AL
- KMID: 2520130
- Gut Liver.
- 2021 Sep;15(5):782-790.
- doi: 10.5009/gnl20297
Background/Aims: Bisphosphonates are increasingly recognized for their anti-neoplastic properties, which are the result of their action on the mevalonate pathway. Our primary aim was to investigate the association between bisphosphonate... -
- CITED
-
- Close
- SHARE
-
- Close
